Nucleic acid testing and tissue safety: An eye bankês five-year review of hiv and hepatitis testing for donor corneas

Cornea

Volumn 32, Issue 4, 2013, Pages 503-505

  Heck, Ellen ^a   Brown, Allen ^a   Cavanagh, H Dwight ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

HIV window; nucleic acid; serology test

Indexed keywords

VIRUS DNA; VIRUS RNA;

CORNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; EYEBANK; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; NUCLEIC ACID TESTING; ORGAN DONOR; PRIORITY JOURNAL; PROCEDURES, PARAMETERS AND DEVICES; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; TISSUE ALLOGRAFT SAFETY;

CORNEA; DNA, VIRAL; EYE BANKS; HEPACIVIRUS; HEPATITIS; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMANS; LIVING DONORS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, VIRAL;

EID: 84875228245     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182653a7a     Document Type: Review

References (4)

1. Food and Drug Administration. Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (X. References) 21 CFR Part 1270. Silver Spring, MD: U.S. Food and Drug Administration.
2. Food and Drug Administration. 21 CFR Part 1271.27 Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/P) Registration of HCT/P Establishment, Form 3356. Silver Spring, MD: U.S. Food and Drug Administration.
3. Ellingson K, Seem D, Nowicki M, et al; For the Organ Procurement Organization Nucleic Acid Testing Yield Project. Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United states. Am J Transplant. 2011; 11: 1201-1208.
4. Pruss A, Caspari G, Krüger DH, et al. Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis. 2010; 12: 375-386.